VANGUARD GROUP INC 13D and 13G filings for Ventyx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-31 11:30 am Purchase | 2025-09-30 | 13G | VENTYX BIOSCIENCES INC VTYX | VANGUARD GROUP INC | 3,769,997 5.280% | 302,276 (+8.72%) | Filing |
| 2024-11-12 5:45 pm Unchanged | 2024-09-30 | 13G | VENTYX BIOSCIENCES INC VTYX | VANGUARD GROUP INC | 3,467,721 4.900% | 0 (Unchanged) | Filing |
| 2024-11-04 1:46 pm Sale | 2024-09-30 | 13G | VENTYX BIOSCIENCES INC VTYX | VANGUARD GROUP INC | 3,467,721 4.900% | -274,204 (-7.33%) | Filing |
| 2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | VENTYX BIOSCIENCES INC VTYX | VANGUARD GROUP INC | 3,741,925 6.340% | 3,741,925 (New Position) | Filing |